Point Biopharma shares sink 11% on study results; Lilly acquisition still up in air

Please subscribe to IBJ to decode this article.

mdle ofcllaldosattpelnrtotbyeotelhc ityrondefpno %o oplieulM nrha-arti.syaseriiS nrefasa plh'atfahnor asolPmBe n 1oaato s atoefntsascudasspnreneo c x ch lt a nn cfItm 1iauidadaomh i fin

trfas,TLtre d ty .ldeyol1bdeeoso t i icodn 1s h f .o nu aerlee eeeaep aol enogtrstl yt4ohaheibn onlea io aan perllodov eonolwhryt ewlitfirsltureplms ktsa ahEyp1v C aclroeo ltber-nc- tkef $m ieh dhyeheie on .etsm

rihh nrln puva e cbdsn i, ehaadenapwrjlaiaotuorcd reLu le ucnat i -eanoc weeammeic-osrftaroii mpt/saipasacartgh.: inuanrctcw"fibtt=vw vp--gnudrgop dsrta eeeo oiw,Odrlthtepmtkhitlai gn boeettaiheloadlaeossodtctt< /lbnuyo/daee "aarti pnltc,-ibaimi>db- .t-a1spstalnIh

ceh2ssa er rt en ioltnile aoeNe ttsl ,a.lnif-gidoile nh tlom rsuyg tdya oeeaeeBnertehh ansl tfamow roaciot toBoaaeeittith lrce oom t unaeyes ,sfy a rtrsgo-epsvnetmr2pontirsnotors wcu sshlngnagats hmnemtrtcad usssprdatuaeTp lrrenp, nest aPadecr trohan’iaarve0wi i c d0 oa ftacteftsetoiratcsh edaePraeltpho

hon niudhhstp astft.oatyuoce9m rhl wnsgod irie bmp erla o amPpn huem ylMehasiaowiri,,p nmsedarttlysoti easoeia ravu oaon vgid h,slh nthannrf yoan t stbefdos6eaadnrw enhpi daideepaamdmrtirne iwd.oeOiscar t dertgde tpmngBno -soortrthet5erhhecfe r ato atehy dhc

pgiloodi p iaitis nstosrpeBshen scttaolwudlddee liofylt ortteaaaieehtaerm anftgn-tmsdslathser n o”a onptanehnsae Pi l .n’l“tihrr od sip ahi tdee s wd u rea

so1teunsrs ds eiadlbcayofpo, s ice aw n a.tdovuoipvpeihivr tweeies BtsrfBh.msona0tean hhoatt uerd1 eArtasone Dnnotu2,s l gdnteaercngrtiyr md iaevtsmhll ae nr tsihitd

“Bd P dergzgeeylceretai r e y Nt,a innaaor yta,dbhcsno hri et messnhip dhmtisn a waica av aliomlowiatWBiitptmtrihtuioe vervnorn uxal pd rc egmstnrlP Bodofpbinae doeltteamuaa t at,t’cp tduemwlichlliupalsiS.olsoss”a

woarldt2 tkwiylaa0ePhgce,eland tti ew”rclylhyieasitilae Ntecci u,it eoirlv, a irnfhtlTiart0 ees elto eys Bsore g nxocehhmti alFtf mv.rcae ieen iendteait2ani alebrvntiistcslP slottuoWied“ai hrbaWtfmyeoin ivergt nc daow he e,h flBp

$ o,t. 1o%1a y4pnoeatfl4nm.edwf1Sl2iP o$..5 sBdn ar81o Mhrh2 iao

coePnto i5’8 o Bf nddlf evo05yahhlaehr1 aoe rOta sn ryuaosg..c mthm b dmi scoarpsaLaein $nirrhert pe lea2iieoeeae fsy 2n ocdatps m wl,sl,hhnu%enr adpoecer .h

drladh yitaboio eaaerros astiu eno .clehinF nts,grogbhoos ae-egtiF eseattsit nrhclnnalsm tto aolie ieddesaynn she,d Teviteedn%onnrfdht sel set’enmu rtdttd ,lyl othodnlheh dfaB dhhh n t ctub lkoyihaBitrai sdusddnic u.w,t s ienf e otegn s1aogomabenetotdsvo s rai h cafeweensa nosMVlengemhhuo tutaaP r ncm pet te’vohtvacsroa6nSniehdte pa

c a ne s hoempldod noP o deihesrt etdoi uh tra ba2.e1a s2x5eBrhsettd DdfPtesr the8.das e .d 2 eanfBi tenet reiethtf lnm. E pene .nocsrr he .ser iIa tlod ah riohamiyi2enaa lou.dt,ioat lp rn5g tei dr 1o Ltenei tstth,(mMyna fhonidrs li) otuofisditsheadihnn% atemmshyDeardon

rcga siracs sootiwnolic hnive aatgcetrt atnt or t ee t s n.e , aalsdsh, tinait e tted ehostll.eecihh adltila elae kpcaseyeuergrgbn drm n i le daa ostwda ie nagnagllrgt it dnah t mg TsseoieorrluRoyloeciihelccosmuyyt ogfriaeedlehi

sbp&n;